Stereotaxis announced on November 6, 2024, that physicians at the University of Kansas Health System successfully treated their first patients using the advanced Genesis Robotic Magnetic Navigation (RMN) System. The University of Kansas Health System is recognized for its expertise in diagnosing and treating complex heart conditions. This adoption signifies an expansion of advanced robotic heart care within a leading U.S. medical institution.
The Genesis System represents the latest advancement in Robotic Magnetic Navigation technology, which brings robotic precision and safety to cardiac ablation procedures. Cardiac arrhythmias, affecting millions globally, can lead to serious health risks if left untreated. The system aims to enhance the effectiveness and safety of these minimally invasive treatments.
This new installation at the University of Kansas Health System underscores the growing clinical acceptance and demand for Stereotaxis' robotic solutions. Such adoptions are crucial for the company's strategy to increase its installed base and drive future recurring revenue streams from disposable catheter use in procedures.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.